{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:54:09Z","timestamp":1791352449431,"version":"4.3.1"},"reference-count":29,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1498,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1111\/j.1365-2036.2011.04784.x","type":"journal-article","created":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T01:03:42Z","timestamp":1311728622000},"page":"649-655","source":"Crossref","is-referenced-by-count":63,"title":["Aspirin in the aetiology of Crohn\u2019s disease and ulcerative colitis: a European prospective cohort study"],"prefix":"10.1111","volume":"34","author":[{"given":"S. S. M.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Luben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Boeing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tjonneland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Overvad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kaaks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-T.","family":"Khaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Riboli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. R.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,7,26]]},"reference":[{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ibd.20301","article-title":"Quality of life of patients with ulcerative colitis: past, present, and future","volume":"14","author":"Irvine","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"Suppl. 4","key":"10.1111\/j.1365-2036.2011.04784.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2036.2004.02046.x","article-title":"Review article: colorectal carcinoma and inflammatory bowel disease","volume":"20","author":"Eaden","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","article-title":"Epidemiology and natural history of inflammatory bowel diseases","volume":"140","author":"Cosnes","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB4|cit4","unstructured":"Visiongain. Inflammatory Bowel Disease: World Market 2010-2025"},{"issue":"Suppl.","key":"10.1111\/j.1365-2036.2011.04784.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0016-5085(89)80060-5","article-title":"Epidemiologic evidence on the association between peptic ulceration and antiinflammatory drug use","volume":"2","author":"Langman","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2036.2007.03348.x","article-title":"Determinants of the short-term gastric damage caused by NSAIDs in man","volume":"26","author":"Bjarnason","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/gut.41.3.344","article-title":"Mitochondrial damage: a possible mechanism of the \u201ctopical\u201d phase of NSAID induced injury to the rat intestine","volume":"41","author":"Somasundaram","year":"1997","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1046\/j.1365-2036.2000.00723.x","article-title":"Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat","volume":"14","author":"Somasundaram","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nsb0895-637","article-title":"The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase","volume":"2","author":"Loll","year":"1995","journal-title":"Nat Struct Biol"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/cyto.2002.2007","article-title":"In vitro effects of eicosanoids derived from different 20-carbon fatty acids on production of monocyte-derived cytokines in human whole blood cultures","volume":"20","author":"Miles","year":"2002","journal-title":"Cytokine"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1161\/01.ATV.0000184757.50141.8d","article-title":"Novel mechanism of vasodilation in inflammatory bowel disease","volume":"25","author":"Hatoum","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/gut.40.5.619","article-title":"Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease","volume":"40","author":"Evans","year":"1997","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/j.1572-0241.2000.02262.x","article-title":"Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study","volume":"95","author":"Felder","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1365-2036.2003.01519.x","article-title":"Non-steroidal anti-inflammatory drugs, aspirin and newly diagnosed colitis: a case-control study","volume":"17","author":"Gleeson","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/BF01536701","article-title":"A meta-analysis of the role of smoking in inflammatory bowel disease","volume":"34","author":"Calkins","year":"1989","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1111\/j.1572-0241.2000.02263.x","article-title":"Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease","volume":"95","author":"Bonner","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1572-0241.2002.05608.x","article-title":"Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease","volume":"97","author":"Mahadevan","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.cgh.2007.04.031","article-title":"Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study","volume":"5","author":"Maiden","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s10620-006-3103-5","article-title":"Relapse of inflammatory bowel disease associated with use of nonsteroidal anti-inflammatory drugs","volume":"51","author":"Meyer","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1189\/jlb.0303116","article-title":"Prostaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells","volume":"74","author":"Jing","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0006-291X(86)91224-6","article-title":"Regulation of macrophage tumor necrosis factor production by prostaglandin E2","volume":"137","author":"Kunkel","year":"1986","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.4049\/jimmunol.180.4.2125","article-title":"Prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN-beta production","volume":"180","author":"Xu","year":"2008","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0014-2999(94)90113-9","article-title":"Pro-inflammatory and anti-inflammatory effects of the stable prostaglandin D2 analogue, ZK 118.182","volume":"261","author":"Pons","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"20979","DOI":"10.1073\/pnas.0707394104","article-title":"Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2","volume":"104","author":"Rajakariar","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1136\/gut.34.11.1531","article-title":"Neoterminal ileal blood flow after ileocolonic resection for Crohn\u2019s disease","volume":"34","author":"Angerson","year":"1993","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/gast.2000.16510","article-title":"NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2","volume":"119","author":"Wallace","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04784.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0016-5085(03)00699-1","article-title":"Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation","volume":"125","author":"Hatoum","year":"2003","journal-title":"Gastroenterology"}],"container-title":["Alimentary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2011.04784.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2036.2011.04784.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T17:20:05Z","timestamp":1613150405000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/j.1365-2036.2011.04784.x"}},"subtitle":["Aspirin in the aetiology of inflammatory bowel disease"],"short-title":[],"issued":{"date-parts":[[2011,7,26]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04784.x","relation":{},"ISSN":["0269-2813"],"issn-type":[{"value":"0269-2813","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,26]]}}}